rfhg_45358.1

Basic information about the TSS

---

TSS ID: rfhg_45358.1 Species: human Chr: chr3		Start: 49940135 End: 49940177 Strand: +
Source datasets	PRJNA401781|PRJNA548673|PRJNA615891|PRJDB5282|PRJNA4843412 |DRA013844|PRJNA597322
Protocol	CAGE|RAMPAGE|oligo_capping|ReCappable-seq|SLIC_CAGE|C1CAGE |NETCAGE|TIF-seq2|STRIPE-seq
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3425748,EH38E2200710)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000454079.5:0 ENST00000266022.9:0 ENST00000425608.5:0 BX648535:0 AK308794:0 AK303371:0 AY216800:0 AK093836:0 AF091264:0 BC030057:0 GeneID: 10180 HGNC/MGI_ID: HGNC:9903 UniProt_ID: B3KSK6 F8WCA5 P78332 Q6K043 Nearer transcript ids and distances: ENST00000434592.5:9 EF566883:9 EF566884:9 EF566885:9 BC046643:13 AF042857:14 ENST00000422955.5:-33 ENST00000493652.1:-38 AL832236:-39 AF069517:-40 ENST00000441115.5:-61 ENST00000419610.5:-72 AK298108:-72 AK291719:-91 ENST00000443081.5:-94 ENST00000442092.5:-128 LF378455:137 MA614032:137 ENST00000433811.1:284 ENST00000491874.5:362 view more...

Gene_name: RNA binding motif protein 6 Gene_symbol: RBM6 Gene_synonyms: 3G2 DEF-3 DEF3 NY-LU-12 g16 Gene_source: HGNC:9903

TATA-Box annotation

---

Distance to TSS:	6
Nearest PromoterID:	NM_001349194
Entrez ID:	10180
Nearest Unigene:	Hs.696735
Nearest Refseq:	NM_005777
Nearest Ensembl:	ENSG00000004534
Gene Name:	RNA binding motif protein 6
Gene Alias:	3G2|DEF-3|DEF3|HLC-11|NY-LU-12|g16
Gene Type:	protein-coding
CpG%:	0.190476
GC%:	0.767442
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RBM6 p2@RBM6 p3@RBM6 p4@RBM6 p5@RBM6 p7@RBM6 p8@RBM6
Sample		p1@RBM6	p2@RBM6	p3@RBM6	p4@RBM6	p5@RBM6	p7@RBM6	p8@RBM6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	16.17	6.23	2.34	8.18	4.09	0.78	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	15.38	7.49	4.45	7.08	4.05	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.75	6.94	1.93	6.94	3.67	1.16	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.85	5.41	2.91	4.16	3.74	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.50	6.75	2.25	6.75	2.92	0.22	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.82	4.65	1.94	5.23	2.52	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.48	6.75	3.49	5.45	4.58	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.59	9.93	4.84	4.60	4.36	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.52	4.70	2.99	4.27	3.21	0.43	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	27.24	8.11	5.80	6.96	6.38	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.47	11.72	7.68	6.87	4.04	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	25.21	8.54	4.07	8.13	3.66	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.89	2.10	1.77	0.81	0.97	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.68	1.35	1.05	0.75	1.05	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.10	2.42	0.88	1.10	2.20	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.07	1.51	2.26	0.50	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.67	1.09	0.44	0.66	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	0.84	0.00	0.42	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	1.60	2.13	0.00	2.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.99	1.35	2.56	0.60	0.60	0.00	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.63	1.60	0.94	0.67	0.80	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.29	2.76	0.86	0.86	1.38	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.60	0.78	1.55	0.39	1.03	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.65	2.43	0.73	1.21	0.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.84	1.29	1.81	0.00	0.77	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	1.58	0.00	0.63	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.69	2.20	0.55	0.55	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.67	2.59	1.65	0.24	1.65	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.05	1.78	1.62	0.65	0.48	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.22	2.53	1.99	0.90	0.54	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.42	1.67	0.84	0.63	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.87	0.78	0.59	0.39	0.59	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.13	1.48	0.63	1.27	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	11.55	1.81	1.81	0.16	1.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.35	1.12	1.12	0.37	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.69	1.72	1.15	0.19	0.57	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.24	2.66	1.23	1.23	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.47	1.41	0.00	1.01	1.21	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	1.08	0.27	0.81	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.20	2.64	0.96	1.20	1.68	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.70	1.41	0.94	0.71	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.32	1.17	1.17	0.88	1.17	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.01	1.05	0.63	1.05	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.14	1.22	0.87	0.70	0.70	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.04	1.20	1.00	0.20	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.31	2.56	1.86	1.63	0.93	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	2.64	0.96	1.44	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.94	1.19	0.60	0.89	0.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.05	1.44	0.48	0.96	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.33	1.42	0.81	0.81	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.81	3.07	0.82	1.23	1.02	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.90	3.56	2.22	2.00	0.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.03	0.71	0.00	0.71	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.62	0.66	0.33	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	5.03	3.36	0.00	1.68	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	4.59	4.59	0.46	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.81	1.94	0.32	1.62	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	2.57	0.96	0.64	1.28	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.35	4.09	1.89	1.57	1.89	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	2.12	0.71	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	1.12	0.00	1.12	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	6.37	1.59	0.80	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.57	3.74	2.04	0.34	1.36	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	2.92	0.32	0.97	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.03	2.13	0.71	0.71	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	32.33	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	15.79	0.00	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	0.00	0.49	0.98	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	1.49	0.50	0.99	0.99	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	11.73	2.35	0.94	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.56	2.32	0.33	1.32	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.19	0.93	0.93	0.00	0.62	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	1.53	0.61	1.22	0.31	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	16.95	2.38	1.43	2.06	1.74	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	11.07	2.57	1.44	1.76	1.12	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	13.10	2.16	1.02	1.15	1.15	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	10.46	1.49	0.00	0.00	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	2.68	1.00	0.67	1.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.23	1.28	0.64	1.91	1.28	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	0.00	0.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	0.00	0.00	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.52	1.04	0.35	0.17	0.00	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	26.60	3.52	1.17	2.15	1.17	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	6.69	0.77	2.83	1.03	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	21.19	3.62	0.56	1.95	0.84	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	11.76	5.29	1.76	2.35	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	28.63	5.23	2.98	3.46	2.65	0.00	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	4.52	2.26	1.29	1.29	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	1.60	2.67	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	3.90	1.67	0.56	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	15.80	7.49	1.66	3.74	2.50	0.00	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	14.32	2.26	1.26	3.77	0.75	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	14.40	5.56	1.31	3.60	4.58	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.48	3.35	0.91	5.18	1.83	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	5.75	0.88	0.88	1.10	0.66	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	1.43	0.36	0.00	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.71	2.34	0.00	1.80	1.08	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	1.67	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	1.23	0.41	1.03	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	15.22	1.26	1.14	0.69	0.92	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	7.59	1.22	0.00	0.73	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	0.90	0.90	0.45	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.81	3.04	0.43	1.30	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.86	2.39	0.00	0.90	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	0.00	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	4.62	0.66	0.66	0.66	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	1.95	0.32	1.62	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	1.46	0.49	0.49	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	1.78	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.17	1.51	0.38	0.38	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	3.63	1.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	2.51	0.00	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.25	2.14	0.66	1.15	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.07	1.21	0.30	0.45	0.15	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	1.07	0.54	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.23	1.51	0.00	0.57	0.19	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.88	1.60	0.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	0.98	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.47	1.16	0.00	1.00	0.50	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	0.00	0.00	0.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.97	0.69	0.00	0.86	0.69	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	0.49	0.49	1.46	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.69	1.52	0.38	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	1.21	0.00	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	2.28	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.34	0.64	0.21	0.86	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.36	2.06	0.52	0.52	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.10	0.47	0.47	1.41	1.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	6.11	0.96	0.00	0.32	0.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	2.14	0.00	0.00	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.26	0.58	0.00	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.72	0.30	0.30	1.51	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	0.00	0.00	2.38	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	1.02	0.00	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.40	1.02	1.53	0.76	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	3.18	0.00	1.27	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	1.29	0.00	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.08	1.06	0.42	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.06	1.16	0.58	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	0.94	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.44	1.36	0.68	0.68	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	1.93	0.64	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	1.80	0.00	2.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	1.46	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.98	1.15	0.23	0.92	0.69	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	0.51	0.25	0.76	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.78	1.86	0.21	0.62	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	0.92	0.31	2.45	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.17	2.39	0.00	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	1.11	0.00	0.67	0.67	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.98	2.22	0.55	0.55	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.03	1.59	1.06	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.00	0.00	0.00	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.90	1.11	0.12	1.23	0.61	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	9.07	2.40	0.17	1.54	0.86	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.39	1.05	0.21	0.21	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	36.25	1.05	1.74	1.05	1.74	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	27.02	3.40	2.43	1.13	1.62	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	31.47	5.07	2.39	1.49	1.79	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	50.23	4.59	2.64	1.95	1.38	0.57	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	55.37	4.51	2.38	2.76	1.75	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	45.75	5.69	2.84	1.14	1.93	0.46	0.00
Basophils, donor1	12241-129G9	17.78	2.09	0.78	1.05	0.00	0.00	0.26
Basophils, donor2	12242-129H1	38.24	11.18	5.05	4.33	3.25	0.36	1.80
Basophils, donor3	12243-129H2	23.37	2.65	1.18	0.88	1.76	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	3.23	0.22	0.43	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	1.37	0.46	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	0.00	0.63	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.36	1.04	0.00	0.62	0.83	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	9.21	0.23	0.00	0.69	0.23	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.60	1.08	0.54	1.26	0.36	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	104.91	12.06	7.32	8.14	7.52	0.93	5.67
Burkitt's lymphoma cell line:RAJI	10476-106I8	92.46	11.18	5.59	6.52	3.26	1.40	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.22	4.80	1.28	2.88	1.60	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	30.43	3.38	3.94	2.25	0.56	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	27.47	5.94	2.78	0.37	1.67	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	26.34	5.49	3.51	1.10	2.63	0.66	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	35.95	2.55	1.42	2.26	1.70	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.12	3.41	4.55	1.90	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.04	4.60	2.63	1.31	2.96	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	22.69	2.02	1.16	1.16	1.01	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	14.79	1.21	0.91	0.91	1.21	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	20.14	1.90	1.18	2.13	0.71	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.06	2.85	1.00	0.84	0.50	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.73	2.21	0.28	1.66	2.21	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.59	1.74	0.74	1.49	1.24	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.14	1.17	0.59	1.37	0.78	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.60	1.25	0.71	1.42	0.89	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	1.74	0.87	1.09	0.22	0.44	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.24	1.64	1.17	0.94	0.70	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	17.95	2.11	1.58	3.17	1.58	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	2.22	0.00	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.47	1.64	0.00	1.04	0.45	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.76	2.39	0.40	1.20	0.80	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	24.57	1.46	0.62	1.87	0.62	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.41	1.83	0.69	1.37	0.92	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.29	1.13	0.90	1.36	1.81	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.91	2.18	1.31	1.75	1.75	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	16.14	1.08	0.27	1.61	1.08	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	20.41	1.05	1.74	1.74	0.87	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	20.20	2.10	1.26	2.10	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	12.68	1.65	0.00	0.92	0.73	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.44	1.06	0.35	1.06	1.76	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	0.44	0.44	2.63	1.75	0.44	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.08	1.39	0.87	1.05	1.57	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	11.52	1.49	1.86	1.49	1.12	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.93	2.16	1.29	3.66	0.65	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.02	2.05	0.00	0.82	0.82	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.14	1.39	0.93	0.93	0.93	0.00	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.98	2.09	0.46	2.09	0.46	0.46	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	29.86	0.87	0.22	0.22	1.31	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	26.33	0.92	2.08	0.46	1.15	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	28.81	1.95	0.65	0.43	1.30	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	57.15	2.02	2.34	0.93	3.11	1.09	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	39.29	1.75	1.05	0.70	1.92	0.70	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	78.04	8.47	3.79	1.78	3.12	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	32.92	1.53	0.26	0.00	1.28	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	32.93	0.88	0.22	0.22	1.54	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	40.21	2.53	0.21	0.63	2.11	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	4.06	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	111.87	5.42	2.03	4.07	5.42	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	118.06	4.14	3.11	1.04	2.07	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	108.74	6.93	2.13	1.07	2.13	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	153.32	3.75	4.29	1.07	1.07	1.61	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	113.01	8.42	2.81	2.11	4.21	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	8.63	1.57	1.57	3.14	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	113.37	6.59	0.00	1.32	3.95	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	68.22	7.40	2.47	1.64	5.75	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	50.05	4.35	5.08	0.00	3.63	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	38.87	3.03	2.02	1.01	2.02	4.04	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	35.56	16.97	7.27	11.72	8.08	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	28.76	16.78	6.79	9.59	3.99	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	38.15	2.01	1.00	0.00	3.01	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	53.93	7.87	1.12	2.25	1.69	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.22	6.01	3.38	2.63	0.38	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.45	6.76	3.38	2.93	2.25	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	61.41	19.64	11.07	2.14	5.00	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	37.97	13.47	9.80	2.45	5.51	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	40.56	12.50	6.10	2.74	3.66	1.52	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	59.98	8.68	3.83	0.77	2.55	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	47.39	5.17	2.92	0.45	1.35	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	69.28	7.47	5.75	1.72	2.59	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	54.99	12.80	11.38	1.90	4.74	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	48.46	14.05	8.43	2.11	4.92	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	16.48	13.18	0.00	13.18	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	45.09	6.21	3.32	1.45	1.59	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.01	4.07	2.88	1.36	1.19	0.17	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	39.66	9.35	2.74	1.61	1.93	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	44.38	6.72	4.48	3.14	1.34	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.75	8.39	5.59	0.35	1.40	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	64.24	16.72	4.84	1.76	3.52	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	70.41	10.12	2.95	2.95	1.26	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.19	9.97	3.53	1.66	2.29	1.04	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	45.78	7.35	4.34	3.68	1.67	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	69.62	16.04	10.33	2.18	3.81	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	72.35	21.97	12.86	1.61	4.82	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	98.63	19.73	8.97	3.59	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	71.95	9.83	4.08	2.23	4.26	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.96	6.72	3.90	1.52	1.52	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.65	11.14	6.30	2.73	2.31	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	56.12	13.15	8.09	1.01	4.04	2.02	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.49	8.23	7.37	2.17	4.33	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	74.09	25.28	7.41	4.79	3.05	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	74.73	19.30	10.89	1.98	7.42	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	67.39	14.77	9.23	2.77	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	47.46	9.77	9.77	1.40	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	134.59	27.14	6.09	3.32	8.86	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	155.82	30.43	6.38	3.19	9.82	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	9.24	12.32	1.54	7.70	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	88.81	15.76	10.03	3.58	4.66	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	80.33	15.23	8.31	2.77	6.92	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	46.16	19.32	9.17	3.93	4.26	0.00	2.62
CD8+ T Cells, donor2	11307-117C2	38.29	16.89	7.88	3.38	2.25	1.88	0.75
CD8+ T Cells, donor3	11383-118B6	44.44	15.91	5.55	2.02	3.53	3.53	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.93	2.98	0.23	2.06	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.90	4.31	0.00	0.96	0.96	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.86	2.46	0.82	2.19	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.41	2.70	0.60	1.50	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.92	1.68	0.48	1.92	1.20	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.55	2.73	0.68	1.14	0.45	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.17	2.17	0.87	1.52	0.87	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	2.63	0.79	0.53	1.32	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.60	2.81	1.64	0.70	1.17	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.23	3.92	0.00	0.91	1.81	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.56	2.32	0.58	1.74	1.45	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.85	1.87	0.00	2.40	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.95	1.31	0.88	1.31	0.44	0.00	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.04	3.19	1.37	1.82	1.82	0.91	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	2.24	0.75	1.49	2.24	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.49	3.60	1.08	1.08	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.67	3.45	1.15	1.44	0.86	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.73	2.12	0.47	1.65	1.18	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	3.49	0.95	1.27	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.07	2.15	1.54	0.62	0.62	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.27	1.92	0.00	3.53	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.65	3.82	0.76	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.73	2.76	0.00	0.00	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	16.64	3.03	0.00	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	41.75	4.82	0.80	1.61	0.00	0.80	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.87	4.20	2.80	0.70	2.80	0.70	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	5.01	1.00	0.00	2.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	21.93	1.83	3.66	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	0.00	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.73	1.16	0.74	0.53	0.53	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	20.80	4.51	1.04	1.39	1.04	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.88	1.07	1.78	1.07	0.00	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	15.02	2.50	1.14	0.68	0.34	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	32.23	6.27	0.90	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	17.39	1.62	0.40	2.43	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	28.69	3.79	2.18	1.15	1.26	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	16.46	3.21	1.92	2.14	0.43	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	16.90	3.01	1.68	1.24	1.24	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	41.17	7.89	4.13	4.68	2.66	0.28	0.92
Corneal Epithelial Cells, donor1	11526-119I5	6.37	0.00	0.22	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	0.00	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.37	1.02	0.26	0.77	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.24	2.15	0.99	0.99	1.49	0.17	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.08	0.95	2.21	0.95	0.63	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.03	1.40	0.54	0.76	0.86	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	47.49	20.50	7.52	7.17	5.47	1.02	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	48.97	22.20	7.83	4.57	4.57	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	61.94	22.75	3.39	7.74	7.74	2.42	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.34	2.00	0.83	0.33	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	0.59	0.00	1.17	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	1.41	0.57	0.57	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.86	0.79	0.79	0.79	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	6.40	2.91	0.29	1.45	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	10.82	1.65	0.47	1.41	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	7.89	1.58	0.88	1.23	0.35	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.83	3.99	0.89	1.99	1.11	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.56	1.52	0.91	2.74	0.91	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.34	3.10	0.56	4.23	2.26	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	12.78	1.19	0.00	1.19	0.89	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	3.64	0.52	1.04	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.51	0.57	0.14	0.71	0.00	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	22.81	2.00	0.00	3.60	2.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	1.57	1.05	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	32.68	3.73	1.62	1.74	0.87	0.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.33	3.26	1.09	0.43	0.87	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.52	4.03	1.34	2.93	0.49	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	11.38	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	0.70	0.00	0.00	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	9.26	0.94	0.31	0.94	0.47	0.00	0.00
Eosinophils, donor1	12244-129H3	15.25	15.25	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	23.10	8.25	1.65	16.50	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	21.40	3.57	0.00	17.83	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	1.47	0.00	0.24	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	1.64	0.82	2.46	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1.42	0.44	0.11	0.55	0.11	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.74	0.76	0.11	0.43	0.33	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.62	3.03	0.85	1.94	0.97	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	29.75	5.87	3.14	7.78	1.36	0.55	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7.91	1.37	0.42	1.05	0.74	0.21	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.83	6.85	2.11	2.37	3.16	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.27	2.99	2.33	1.66	0.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	5.44	0.91	0.45	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	3.03	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	4.89	1.26	0.47	1.26	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	28.19	2.42	2.42	2.42	0.30	0.30	0.91
Fibroblast - Cardiac, donor5	11456-119A7	16.12	1.90	0.89	1.14	1.52	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	19.25	3.03	0.15	1.67	1.06	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.95	2.55	0.40	1.21	0.80	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.33	2.16	1.29	0.86	1.29	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	2.93	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.61	1.85	0.46	1.15	0.46	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	24.76	4.75	2.71	0.68	0.85	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	7.04	1.64	0.70	0.47	1.41	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	8.49	2.83	1.89	0.94	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.37	0.97	0.97	0.36	0.36	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	19.33	2.60	0.90	1.24	1.36	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	17.27	4.88	2.09	0.70	2.09	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	17.05	2.92	1.30	1.46	1.95	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	19.16	1.46	0.83	1.87	2.08	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.39	2.62	1.31	2.36	1.05	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	17.53	3.16	1.45	1.58	1.84	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.92	2.32	1.45	0.97	1.16	0.10	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	0.00	2.08	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.40	0.88	0.88	0.70	0.18	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.43	3.27	1.40	1.87	1.71	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.47	2.84	0.68	1.08	1.35	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	5.65	0.35	0.35	0.00	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.92	3.22	1.17	1.17	1.17	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	13.36	2.86	1.36	1.36	0.55	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.04	2.74	1.76	1.43	0.88	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.07	2.49	2.49	1.03	0.29	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	6.80	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	2.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	11.61	1.27	0.63	1.27	0.84	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.00	0.00	0.83	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	0.84	0.00	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.18	4.47	0.41	2.03	2.03	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	21.92	2.33	3.30	1.55	0.39	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	25.33	4.55	3.03	2.28	1.97	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.81	2.75	2.14	3.98	2.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.12	3.05	0.38	0.76	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	10.80	1.89	1.62	2.43	0.81	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.02	2.44	1.04	0.58	0.58	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.51	1.44	1.33	1.77	0.99	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.72	1.22	0.61	1.83	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	0.00	0.67	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.28	0.79	0.40	1.19	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.32	9.92	1.59	2.78	2.78	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.08	1.24	1.78	1.24	0.53	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.29	4.34	2.76	1.58	0.99	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	35.50	7.22	0.00	1.50	4.51	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.70	2.48	0.76	1.62	2.48	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	49.86	7.59	1.52	3.04	3.04	1.01	0.51
Fibroblast - skin normal, donor1	11553-120C5	13.78	2.46	1.80	1.31	0.49	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.09	8.62	4.61	5.81	2.01	0.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	20.19	2.31	0.90	1.11	1.51	0.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	49.57	7.56	2.12	2.42	3.02	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.49	2.07	1.82	1.41	0.75	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.86	3.42	0.85	1.37	0.85	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	28.57	7.88	0.33	0.66	2.96	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.83	3.41	0.32	1.17	1.49	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	15.69	2.53	0.84	0.84	1.18	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.21	2.04	0.78	0.16	0.47	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	22.16	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.03	8.72	3.49	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.45	3.29	0.52	5.89	0.87	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.19	3.38	0.78	7.55	1.56	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	5.11	1.02	6.90	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	20.67	0.77	0.77	0.00	3.06	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	19.14	0.64	2.55	1.28	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	66.47	5.71	2.57	1.71	3.71	1.14	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	66.46	2.48	2.76	1.10	2.48	0.83	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.67	4.11	3.42	1.83	3.65	1.60	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	47.55	4.56	2.77	1.78	3.37	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	62.38	3.44	2.91	0.79	2.91	1.32	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.29	5.87	1.96	1.30	1.30	0.65	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.11	7.52	2.21	3.54	3.98	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.28	2.12	1.70	0.28	2.54	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.31	2.96	1.60	0.74	1.97	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	2.95	0.81	0.27	2.15	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.54	1.98	2.48	0.50	2.85	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	38.07	2.35	2.49	1.38	1.80	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.85	2.64	2.64	0.81	0.81	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.66	2.05	1.60	0.68	2.05	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	36.87	2.37	2.24	0.75	1.87	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	25.79	3.72	1.31	1.53	1.31	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.75	1.48	1.77	0.00	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.97	2.07	1.91	0.95	1.27	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	22.57	2.23	1.12	0.45	0.67	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	28.23	1.61	1.01	0.40	1.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.04	4.41	1.87	1.36	2.04	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	31.21	3.01	2.39	1.95	2.84	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.11	1.66	2.50	0.83	1.25	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.42	2.05	0.85	0.34	2.22	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.05	2.21	1.00	1.88	1.44	0.00	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.86	3.24	2.83	0.83	1.58	0.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.18	4.08	1.84	1.43	1.84	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	29.71	1.86	2.89	0.21	0.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.00	1.61	1.50	0.58	1.38	0.58	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	27.35	4.67	1.17	0.67	1.50	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.77	1.98	1.54	1.10	1.32	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.23	1.97	1.97	0.86	2.71	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.83	1.78	1.46	1.46	1.13	0.49	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.30	2.57	2.89	0.00	0.32	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.88	2.65	1.42	0.47	1.52	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.40	1.11	1.58	0.00	0.63	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.33	1.82	1.22	0.91	0.61	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.57	3.97	2.09	0.84	1.46	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.08	2.20	1.76	0.00	1.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.80	2.52	1.12	1.12	2.24	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.76	2.59	1.67	0.74	1.57	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.58	1.34	0.80	0.27	1.34	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.30	3.37	0.46	1.07	0.31	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.63	1.55	0.91	0.65	1.55	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.72	1.90	1.90	0.54	0.81	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.20	4.06	1.84	1.11	2.58	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.03	1.32	1.10	1.32	1.97	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	4.96	1.98	0.99	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.70	2.37	1.19	1.19	1.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.75	3.63	1.61	0.81	1.01	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.43	2.80	1.52	0.00	1.52	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	56.93	4.38	1.00	0.40	4.78	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.15	2.31	1.39	0.62	3.85	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	58.72	2.86	2.45	0.41	4.30	0.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.71	0.94	0.63	1.56	1.88	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.08	1.13	1.41	1.41	0.85	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	45.66	4.61	1.38	0.46	4.61	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	2.47	0.00	2.47	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	39.07	1.16	1.93	1.93	2.71	1.16	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	0.00	3.21	0.00	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	3.48	1.74	0.00	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.67	3.58	1.95	0.98	2.93	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	44.89	3.71	0.41	1.24	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	6.66	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.88	1.96	0.84	0.56	1.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	27.45	2.61	1.31	0.98	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	3.36	0.84	0.00	1.68	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	38.80	2.86	2.23	1.59	2.86	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.17	1.02	0.34	0.68	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	2.09	4.18	4.18	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.78	1.72	1.72	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	26.64	0.89	0.59	0.30	0.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	1.69	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.48	2.07	1.24	0.83	1.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.38	3.68	1.15	0.69	1.38	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	2.69	2.31	0.77	1.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.54	1.63	0.33	1.63	2.93	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	15.38	2.68	2.01	0.00	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.29	1.93	1.93	0.77	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	48.95	4.79	4.11	0.00	1.37	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	0.00	0.00	0.00	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	36.80	0.94	1.42	0.47	0.47	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	25.95	1.81	0.60	1.81	1.81	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	43.24	2.03	1.02	0.51	2.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	35.10	3.59	1.99	0.00	0.80	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	47.86	3.45	2.47	0.49	3.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	79.09	9.44	5.90	0.00	2.36	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	31.51	2.33	1.17	1.17	1.17	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.67	2.19	1.76	0.88	1.32	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	1.70	1.70	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	1.79	1.79	1.19	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.03	1.46	0.00	0.49	1.94	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	1.14	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.73	0.42	0.00	0.83	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	3.37	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.88	1.27	0.32	0.32	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	0.00	0.42	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.44	1.51	0.46	0.81	1.39	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.83	1.01	0.84	1.01	0.51	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.83	1.14	0.91	0.68	0.91	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.81	2.19	1.20	0.77	0.77	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.75	2.15	1.29	0.64	0.43	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.36	2.15	0.65	0.65	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.58	1.37	0.37	1.62	1.12	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.32	3.09	0.17	0.69	0.69	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	1.60	0.32	0.64	0.96	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	3.36	0.00	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.92	0.00	0.00	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	2.47	0.00	0.71	1.06	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.18	0.00	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.82	1.75	1.05	0.35	0.52	0.17	0.00
Hepatocyte, donor1	11523-119I2	29.05	4.84	1.21	1.21	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	34.47	6.46	1.08	0.00	4.31	1.08	1.08
Hepatocyte, donor3	11684-122I1	56.45	4.91	3.68	3.07	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.81	20.23	9.79	1.31	5.22	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.93	1.92	2.97	0.52	2.62	0.52	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.76	1.78	1.10	0.82	0.96	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	2.77	0.00	4.15	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	3.33	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	3.63	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	2.65	1.32	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	1.11	1.11	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	1.26	0.00	0.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.11	0.65	0.00	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	0.00	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	1.68	0.00	0.42	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	4.02	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.08	0.94	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	0.91	0.00	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	2.54	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.29	1.91	0.64	1.91	3.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	1.82	1.82	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.14	1.43	0.00	0.00	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.49	0.93	0.31	0.62	1.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	0.00	1.76	1.76	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	1.39	0.70	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24	0.00	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	1.07	0.00	0.00	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	1.39	1.39	0.00	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.00	1.84	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.92	2.37	0.49	4.08	0.82	0.00	0.41
Keratinocyte - epidermal, donor2	11349-117G8	5.86	0.00	0.59	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	15.62	1.89	1.14	1.51	0.66	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	17.03	1.70	1.82	0.79	1.36	0.00	0.11
Keratocytes, donor1	11527-119I6	7.56	2.06	0.34	1.72	0.69	0.00	0.34
Keratocytes, donor2	11607-120I5	5.86	2.34	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	9.48	1.38	0.99	0.20	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	10.99	0.00	10.99	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	3.24	1.08	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.37	0.81	0.69	0.81	0.46	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	10.19	2.62	1.41	0.71	0.61	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.84	0.71	0.24	1.42	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	0.00	0.28	0.84	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.44	1.26	0.16	0.79	0.31	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	0.54	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.73	1.26	0.32	1.58	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.65	0.43	0.32	0.86	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	1.23	0.82	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.05	0.76	0.00	1.01	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.02	0.84	0.28	0.70	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	6.72	1.19	0.40	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.56	0.97	0.78	0.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.26	0.19	0.00	0.37	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.71	1.39	1.05	0.70	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.39	0.72	0.00	0.95	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.38	0.82	0.27	0.82	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	0.92	0.31	0.62	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	0.62	0.00	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.42	1.46	0.37	0.55	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.89	1.97	0.33	1.32	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.15	0.00	0.59	0.88	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.98	0.50	0.00	0.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	3.39	0.97	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	1.35	0.54	0.81	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.69	0.61	0.45	0.30	0.61	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.67	0.52	0.00	0.52	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.52	0.63	0.00	0.84	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.32	0.75	0.45	0.90	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	0.69	0.00	2.75	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.84	1.13	0.00	0.00	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.98	1.06	0.00	0.42	0.53	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.24	0.97	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	0.99	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.96	0.62	0.12	0.50	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.70	3.33	0.37	1.48	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	0.99	0.00	0.74	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.16	1.10	0.14	0.14	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.79	0.96	0.32	0.96	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	14.00	1.22	0.30	1.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.12	0.98	0.00	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.53	1.07	0.00	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.00	0.48	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.11	0.16	0.00	0.47	0.31	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.37	1.07	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	0.65	0.65	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	0.24	0.00	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.16	2.85	0.12	1.24	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	0.60	0.30	0.30	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	4.53	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.14	2.30	0.77	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	3.71	1.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.50	2.12	2.12	2.12	1.27	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	2.81	0.70	0.70	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.93	0.00	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	2.58	1.55	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	0.00	1.19	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.56	0.90	0.68	1.81	0.45	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	7.85	0.87	0.87	1.45	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	2.25	2.70	1.80	1.80	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.91	1.22	0.95	1.22	0.81	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.59	2.05	0.51	0.51	1.03	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.88	1.41	1.41	1.76	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.00	2.00	0.67	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.21	4.08	2.04	1.53	0.00	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.00	1.87	1.87	1.60	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.90	2.08	1.70	1.32	0.76	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.66	3.68	1.23	1.84	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.15	2.45	0.00	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.12	2.29	1.04	2.92	0.62	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.29	2.80	0.56	1.40	1.12	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	1.03	1.03	3.09	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.58	2.61	0.29	1.74	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	2.99	1.20	1.20	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	2.21	0.00	0.55	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	11.67	1.41	1.06	0.71	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	2.95	1.48	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	0.00	1.15	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	5.37	0.77	1.54	2.69	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	1.70	0.57	1.70	0.00	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	1.64	0.00	2.46	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.42	1.36	0.45	2.26	0.90	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	2.87	1.44	1.44	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.98	1.49	0.00	2.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.20	0.74	0.37	1.49	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.17	0.86	0.00	2.15	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	0.86	0.86	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.66	2.33	1.00	2.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.24	3.02	0.60	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.98	0.71	0.00	0.71	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	5.84	1.03	1.03	1.03	0.34	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	0.00	0.00	1.61	1.07	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	0.67	0.67	0.67	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.04	1.48	0.74	2.22	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	0.00	2.33	3.49	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	3.17	1.06	7.40	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.20	1.60	0.00	2.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	2.18	0.73	3.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	5.37	1.53	0.77	4.60	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	1.97	0.49	0.49	1.48	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	0.00	1.88	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.06	0.00	0.00	2.01	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.21	3.15	0.00	2.25	1.35	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	0.00	0.00	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.69	1.78	1.34	3.12	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	5.08	1.17	0.78	2.35	0.00	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	1.32	0.00	1.98	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	8.82	2.59	1.56	1.56	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.31	0.88	1.31	2.63	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	2.24	1.68	1.12	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.95	3.09	0.44	2.21	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5.79	1.93	0.77	2.70	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	9.62	1.01	1.52	3.54	0.51	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.17	0.96	1.44	0.96	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5.17	1.59	0.80	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	8.51	0.61	0.61	1.22	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.92	0.69	0.69	2.77	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	6.84	2.28	0.38	1.90	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.23	3.61	0.52	2.58	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	2.42	0.60	2.42	0.60	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	2.85	2.22	0.00	1.58	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	1.60	1.60	5.33	0.00	0.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.02	1.72	0.00	2.87	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	3.60	1.03	1.03	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	1.41	2.12	3.54	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	2.27	0.00	4.54	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.49	1.66	0.00	2.08	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	0.78	0.78	3.13	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.76	0.84	0.42	1.25	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.97	2.32	1.39	2.79	1.39	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	0.67	0.00	1.34	2.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	1.60	1.07	3.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.68	0.81	2.02	2.02	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	9.18	0.00	0.92	3.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	3.56	0.00	0.89	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.99	3.42	1.14	2.28	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	5.37	1.53	0.77	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.28	1.64	0.55	4.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.24	2.23	0.89	1.34	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	6.50	1.04	0.52	1.82	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	1.33	0.00	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	2.08	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	23.25	1.60	1.60	1.14	0.46	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	15.05	1.28	0.55	1.28	0.73	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	17.17	2.23	0.79	0.66	0.79	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	3.19	0.53	2.66	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	9.67	6.65	0.79	8.56	1.11	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	8.48	6.25	1.39	6.53	0.56	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	23.62	1.10	1.00	1.49	0.30	0.00	0.90
Mammary Epithelial Cell, donor2	11350-117G9	16.79	0.29	1.16	1.45	2.03	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.49	1.25	1.25	1.00	0.75	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	48.81	9.49	2.71	4.07	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	31.79	4.54	1.51	2.60	1.08	0.76	0.32
Mast cell, donor2	11565-120D8	67.46	11.00	5.35	4.75	2.08	1.19	0.89
Mast cell, donor3	11566-120D9	71.14	12.61	5.63	4.50	1.13	0.68	0.45
Mast cell, donor4	11567-120E1	88.47	11.35	4.61	6.03	1.42	1.24	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	42.58	5.54	2.22	3.88	0.78	0.55	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	1.75	0.58	3.50	0.00	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	34.53	4.24	0.80	2.06	1.26	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	36.99	5.02	1.34	3.51	0.67	1.00	2.01
Melanocyte - dark, donor1	11502-119F8	16.42	2.59	0.30	1.19	0.20	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	6.23	2.08	0.69	0.69	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	24.85	2.83	1.67	1.52	0.80	0.07	0.07
Melanocyte - light, donor1	11274-116H5	8.23	2.12	0.24	0.47	0.47	0.24	0.00
Melanocyte - light, donor2	11351-117H1	2.73	0.68	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	27.18	3.75	2.60	1.87	3.12	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	11.03	2.96	0.54	1.08	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	24.37	6.43	1.07	2.95	2.14	0.00	0.27
Meningeal Cells, donor1	11493-119E8	20.10	4.34	0.37	2.11	2.11	0.25	0.25
Meningeal Cells, donor2	11573-120E7	19.81	3.08	0.00	1.76	3.08	0.00	0.00
Meningeal Cells, donor3	11654-122E7	16.38	2.77	1.47	1.30	0.90	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	14.83	2.28	1.14	0.57	0.57	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.15	2.52	0.10	2.21	0.70	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	2.87	0.72	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.13	2.96	1.91	1.48	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	4.02	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.13	1.54	0.88	0.44	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	2.19	0.73	0.00	3.65	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.96	1.64	0.00	0.82	0.61	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	14.82	2.49	0.83	0.55	0.28	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	0.37	0.74	0.37	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	19.87	1.58	1.71	0.92	0.66	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	0.30	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	0.64	0.00	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.82	1.06	0.71	0.71	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.89	1.56	0.63	0.31	0.94	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	1.45	0.00	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	6.10	3.45	1.06	4.24	1.33	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	4.50	3.00	2.00	2.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	6.00	4.05	1.59	4.70	0.87	0.07	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	2.70	2.70	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.21	2.46	0.99	0.74	2.22	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	1.47	0.59	1.77	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	10.37	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	2.48	0.62	1.24	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.54	0.00	0.83	1.04	0.62	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	2.32	2.32	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	14.77	1.00	0.50	0.75	1.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.76	2.33	2.33	0.93	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.21	0.41	0.20	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	1.19	0.00	0.40	1.98	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.88	0.00	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	0.76	0.76	1.14	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	0.00	1.32	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.34	0.85	0.42	0.64	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	0.92	0.92	1.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	0.60	0.30	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	1.00	0.00	0.25	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.13	0.95	0.24	0.24	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	1.11	1.11	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.13	1.38	0.92	0.69	0.92	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.41	1.47	1.26	0.42	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	0.41	0.41	0.41	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.44	1.07	1.29	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.89	0.67	0.44	1.11	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.35	0.88	0.22	0.66	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	1.52	1.01	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	8.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	0.54	0.82	0.27	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.18	1.47	0.59	1.47	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	4.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	0.00	0.00	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	0.80	0.80	1.60	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	5.48	1.37	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.50	1.50	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	2.04	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.44	0.88	0.00	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	4.41	0.00	4.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	7.04	1.28	3.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.69	1.24	0.99	0.74	0.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	1.39	0.70	3.48	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	11.05	2.21	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.60	0.68	1.03	1.03	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	3.50	0.44	2.19	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	3.91	0.36	1.42	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.98	1.40	0.28	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.96	1.66	0.83	3.33	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	1.75	0.58	2.33	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	1.81	0.60	2.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	2.09	0.42	2.50	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	1.85	1.85	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	1.14	0.00	2.85	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.57	1.38	0.55	1.38	1.38	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.63	1.30	0.26	0.78	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.59	1.72	0.86	1.72	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	1.27	0.64	1.91	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.08	2.94	0.80	1.33	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.66	0.90	0.00	0.60	1.50	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.70	1.13	0.42	0.71	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.64	1.27	0.64	1.59	0.96	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.57	2.21	0.22	1.33	1.55	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	3.03	0.38	1.90	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.07	1.70	1.42	0.57	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.47	0.98	0.25	0.98	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	0.65	0.65	1.96	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.11	1.47	0.59	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.13	2.02	0.29	1.15	1.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.37	0.41	1.24	0.82	2.06	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	13.40	2.38	0.89	0.89	1.19	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.83	0.99	0.33	0.66	0.66	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	1.05	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.06	2.77	0.99	0.79	0.79	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	0.00	0.00	0.93	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.89	1.13	0.00	0.75	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.72	0.53	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.85	0.90	0.68	0.45	0.68	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	0.74	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	1.10	0.37	0.73	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	1.07	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	0.00	0.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	1.36	1.36	2.72	0.00	2.72	17.71
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.00	0.00	0.00	0.00	3.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.00	0.81	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	0.00	0.00	0.00	0.00	1.51	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	11.42	0.00	28.55	5.71	17.13	199.86
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	6.52	16.31	6.52	32.62	130.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	4.75	4.75	4.75	0.00	42.77
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00	25.10	62.75
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.13	1.51	0.65	1.94	1.08	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.29	2.09	0.52	0.52	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	0.67	1.33	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	1.67	0.42	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.05	7.04	2.09	1.90	1.90	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	14.36	0.00	4.79	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	0.68	0.68	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	1.84	0.00	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	0.84	0.84	0.84	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.51	2.32	0.70	0.46	0.93	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.94	1.62	0.54	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.77	5.26	0.84	2.10	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	22.27	44.54	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	0.50	0.99	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	2.44	0.81	1.08	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.95	2.27	0.45	1.59	0.68	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.35	2.12	0.82	0.98	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.77	3.10	1.09	1.82	1.46	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	0.53	0.53	1.59	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	1.20	0.00	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	4.27	2.95	3.28	1.97	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.04	2.28	0.65	0.81	0.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.87	3.35	1.23	2.12	0.71	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	3.52	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	1.84	1.38	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	3.21	1.61	0.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.87	3.79	1.03	1.38	2.76	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	12.64	7.59	2.53	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	13.81	2.90	0.22	0.67	0.89	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.39	0.85	0.85	0.85	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.05	4.51	0.95	1.42	0.95	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	2.15	1.72	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	198.61	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	4.33	1.00	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.47	5.41	1.80	1.80	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	3.97	0.00	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.00	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	4.16	1.14	4.16	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2.93	1.63	0.00	1.30	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	1.31	0.00	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.45	5.43	1.36	2.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	0.88	0.00	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	1.99	1.33	0.66	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	2.48	0.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.21	1.53	0.38	0.77	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	21.17	4.54	3.02	0.91	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.92	2.65	1.55	1.55	0.44	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	15.33	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	2.44	1.22	0.61	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.67	2.83	0.31	1.26	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.75	3.03	0.61	0.30	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	1.58	0.79	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	6.80	3.40	5.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	11.43	1.61	1.12	1.12	0.37	0.00	0.12
Myoblast, donor2	11322-117D8	14.77	1.73	0.58	0.96	0.77	0.00	0.00
Myoblast, donor3	11398-118D3	14.63	4.04	2.19	1.85	2.02	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	17.66	4.52	3.36	0.44	0.58	0.15	0.58
Natural Killer Cells, donor1	11230-116C6	55.97	14.45	9.84	2.15	2.77	1.23	0.62
Natural Killer Cells, donor2	11311-117C6	35.28	11.76	5.43	3.02	3.32	2.11	0.90
Natural Killer Cells, donor3	11387-118C1	43.44	15.09	7.55	1.84	2.21	2.02	0.92
Neural stem cells, donor1	11275-116H6	38.47	3.27	4.72	1.09	2.18	0.00	0.36
Neural stem cells, donor2	11352-117H2	59.69	11.55	1.93	1.93	5.78	0.00	0.00
Neurons, donor1	11494-119E9	47.79	5.69	3.41	1.14	4.55	0.00	0.00
Neurons, donor2	11574-120E8	41.61	6.83	3.74	0.88	3.30	0.44	0.22
Neurons, donor3	11655-122E8	49.33	5.76	4.11	3.29	4.11	0.82	0.82
Neutrophils, donor1	11233-116C9	23.20	4.64	0.93	7.42	1.86	0.00	0.93
Neutrophils, donor2	11314-117C9	8.70	2.90	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	20.77	3.05	2.44	4.28	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	12.11	1.31	0.59	0.47	0.47	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	0.33	0.00	0.33	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	9.83	2.41	0.80	0.40	0.80	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.84	2.20	1.24	1.38	0.69	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	13.75	2.46	1.16	1.30	0.43	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	14.53	2.27	1.59	1.59	0.68	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	13.93	2.34	1.07	1.36	0.49	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	23.47	4.81	2.41	2.41	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.08	1.70	0.21	1.91	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	1.14	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	8.69	0.62	0.00	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	13.88	1.37	0.39	0.39	1.17	0.00	0.00
Osteoblast, donor2	11354-117H4	16.86	4.21	2.81	3.51	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	9.60	3.38	0.89	1.07	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	12.47	2.61	1.35	0.93	0.84	0.08	0.00
Pericytes, donor1	11491-119E6	6.23	0.56	0.00	0.22	0.45	0.00	0.22
Pericytes, donor2	11571-120E5	6.34	1.58	0.00	0.45	0.68	0.45	0.23
Pericytes, donor3	11652-122E5	3.26	1.02	0.41	1.83	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	27.01	3.16	1.47	1.47	1.58	0.34	0.11
Perineurial Cells, donor2	11579-120F4	13.53	1.75	1.20	1.20	0.55	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	63.43	11.47	6.06	2.55	5.42	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	39.91	8.57	6.61	0.49	3.43	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	44.91	11.13	5.31	1.55	1.16	0.39	0.26
Placental Epithelial Cells, donor1	11278-116H9	7.89	2.63	1.91	3.59	0.72	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	13.31	2.22	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.44	2.16	0.79	0.79	0.79	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.48	0.32	0.00	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	9.57	1.88	1.13	1.69	0.56	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	36.16	6.92	3.65	5.09	2.22	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	8.56	0.68	0.23	0.68	0.68	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	11.08	1.39	0.85	1.92	0.43	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	11.35	4.80	1.75	1.31	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	10.17	1.86	0.72	1.72	0.86	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	10.83	3.94	0.00	4.92	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.76	1.84	0.31	1.84	0.00	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	9.74	4.07	1.06	1.24	1.24	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	7.83	2.21	0.51	1.36	0.85	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	15.56	3.54	0.93	2.14	0.37	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	11.50	0.92	0.46	0.46	0.92	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	9.51	2.40	0.10	1.25	0.42	0.00	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.49	2.41	1.06	1.21	1.66	0.15	0.60
Prostate Epithelial Cells, donor2	11331-117E8	5.55	2.44	0.68	1.90	0.81	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	8.14	1.10	0.98	0.67	0.31	0.06	0.24
Prostate Stromal Cells, donor1	11254-116F3	11.85	3.19	1.25	2.28	1.14	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	11.12	3.59	1.08	1.79	0.72	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	9.49	2.92	0.63	0.94	0.31	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.84	1.46	1.46	0.73	1.46	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.42	1.87	0.76	2.01	0.76	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	6.59	1.01	0.51	0.51	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	5.69	1.42	1.42	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	17.47	1.06	1.48	1.06	0.74	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	2.04	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.82	1.35	0.27	0.81	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.99	2.66	1.33	1.78	0.89	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.94	1.54	0.44	0.66	1.10	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.15	2.51	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.55	0.55	0.00	0.28	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.59	2.42	0.81	0.81	1.07	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	0.42	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.14	1.16	1.35	0.19	0.58	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.56	1.81	0.78	1.04	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.78	2.56	1.99	0.85	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	1.03	0.00	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.79	1.51	1.25	1.00	1.76	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.89	6.01	3.47	4.68	1.34	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	31.27	7.15	1.79	0.89	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	0.55	0.00	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.10	4.64	0.58	0.00	3.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	39.40	6.24	0.78	1.17	4.03	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.26	3.87	1.49	1.19	2.48	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.46	4.68	2.79	1.56	2.45	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	35.60	5.33	2.23	2.11	2.73	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	24.71	3.85	1.17	0.58	2.80	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	33.75	6.01	1.62	1.39	2.08	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	23.55	5.07	1.23	0.55	2.60	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	22.84	2.72	1.97	1.21	2.42	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	30.28	5.38	1.79	2.33	2.69	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	24.82	3.01	0.72	1.29	2.87	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.03	2.58	1.61	0.75	1.29	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.23	3.98	2.21	1.55	2.66	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.32	6.50	0.76	1.34	2.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.64	4.29	1.58	1.49	1.96	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.07	3.95	2.63	3.38	2.82	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.88	5.71	1.06	1.06	2.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.45	4.09	1.27	1.27	2.73	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.21	3.63	1.91	0.76	2.10	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.63	3.63	0.53	1.07	2.67	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.58	3.08	1.68	1.12	1.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	25.12	4.61	2.91	1.37	1.88	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	29.90	4.38	0.36	0.36	2.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.25	2.82	0.86	1.23	1.47	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.01	5.10	2.01	0.54	1.34	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	26.65	4.25	0.94	0.24	1.89	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.83	4.37	0.99	0.99	2.18	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.53	4.44	2.81	1.64	2.81	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.22	2.90	0.62	0.62	2.07	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	22.34	2.88	1.77	2.21	1.55	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.66	5.64	1.46	1.46	2.72	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.26	5.79	1.35	0.81	2.29	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.48	4.94	1.70	1.02	2.04	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	31.62	4.24	3.08	0.77	2.31	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.62	6.53	0.69	0.86	2.92	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	26.47	4.12	2.88	0.96	2.61	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	30.54	4.10	1.81	1.48	2.63	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.74	4.94	1.02	1.02	2.22	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	26.78	2.96	1.04	0.89	3.26	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.72	4.26	1.07	1.07	2.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	27.10	5.53	0.69	0.97	1.52	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.10	4.05	1.43	1.43	3.33	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	27.81	4.43	3.22	2.62	4.84	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.92	4.24	0.85	0.66	2.92	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	25.85	3.14	2.79	1.05	2.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.34	3.63	0.91	0.60	2.42	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.48	5.26	0.61	0.98	1.71	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.98	10.33	5.68	2.91	4.66	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	4.26	2.43	1.22	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.99	2.71	0.60	0.30	1.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.00	3.17	0.45	1.13	2.04	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.24	5.09	2.40	1.20	1.20	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.35	3.19	0.47	1.89	2.83	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.13	1.92	1.28	1.71	1.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	22.84	4.21	3.00	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	8.84	1.13	0.38	0.38	0.38	0.19	0.19
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.86	2.63	0.44	0.66	0.22	0.22	0.00
Sebocyte, donor1	11220-116B5	18.08	2.19	1.64	3.83	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	6.43	1.38	0.46	1.84	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	5.36	1.24	0.62	0.82	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	8.28	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	25.42	2.82	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	17.68	1.41	1.67	1.50	0.70	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	2.17	0.72	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	9.20	2.51	0.00	0.84	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	15.87	3.61	0.79	0.47	1.41	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	14.27	2.68	1.04	0.89	0.74	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	19.55	4.92	0.92	1.69	1.23	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.92	3.40	1.51	1.13	1.01	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.41	2.43	1.28	0.29	0.57	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.64	3.97	1.79	2.28	1.98	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.92	3.62	1.60	1.18	1.10	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.20	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.02	0.96	0.28	0.28	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	45.66	26.86	5.37	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.17	0.72	0.58	1.30	0.43	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	21.27	4.91	12.27	11.45	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.41	0.91	0.26	0.91	0.91	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.87	2.50	0.28	2.92	1.25	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	11.25	2.53	0.84	1.27	0.56	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.56	11.63	5.07	10.36	5.29	1.48	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	11.99	1.65	1.35	1.05	0.45	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.32	2.16	0.31	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.68	5.11	1.33	3.11	1.78	0.00	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	1.76	0.00	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.85	0.88	0.66	1.10	0.44	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	1.18	0.39	1.18	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	0.77	0.00	1.55	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	18.01	3.00	1.00	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.99	1.33	0.27	0.40	0.53	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.09	1.55	0.44	2.22	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.55	2.05	0.77	1.54	0.51	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	3.26	3.26	1.63	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.74	4.73	2.07	4.13	1.48	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	3.70	1.57	1.85	1.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	1.30	0.16	0.33	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	11.57	2.13	1.22	1.52	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.05	0.51	0.51	0.51	0.76	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	1.91	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.39	0.88	1.47	0.88	0.74	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.99	1.72	1.08	0.43	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.17	2.31	1.36	1.26	0.94	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.96	0.93	0.93	0.77	0.46	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	2.16	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	1.49	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	0.68	0.00	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.50	1.88	1.57	0.55	0.79	0.00	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.88	2.11	0.81	0.70	1.01	0.00	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	9.78	2.05	1.14	1.14	2.28	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	0.60	0.00	0.60	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.10	4.24	2.38	1.32	1.32	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.38	1.46	0.53	1.20	1.07	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.89	2.88	0.75	1.13	0.50	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.39	1.27	0.25	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.25	1.81	0.75	1.36	0.30	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	2.58	0.00	0.00	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.91	1.40	1.40	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	2.02	1.51	0.00	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.01	2.19	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	0.00	0.00	0.59	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.16	2.33	1.75	1.25	1.00	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.74	0.47	0.47	1.40	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.34	1.01	0.86	0.58	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.88	1.27	0.76	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.39	0.75	0.00	0.19	0.19	0.38	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.54	2.79	1.40	0.42	0.98	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.23	1.26	1.01	0.34	0.75	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	0.95	0.00	0.00	0.95	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	0.49	0.24	1.47	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	16.13	3.76	0.66	1.55	0.66	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.00	1.76	0.00	0.88	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.88	4.47	0.97	1.75	0.97	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.40	2.91	1.06	1.32	0.53	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.25	3.72	0.37	1.12	0.37	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	3.59	1.08	3.23	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.69	0.85	0.85	1.42	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.18	4.33	0.00	0.79	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	16.76	0.76	1.02	1.27	0.51	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	12.78	2.40	0.80	0.40	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	5.43	0.42	0.00	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.38	0.46	0.92	0.46	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.82	1.68	0.67	1.18	1.01	0.00	0.00
Synoviocyte, donor2	11368-117I9	14.42	2.85	1.17	1.34	0.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	13.63	2.01	1.12	0.67	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	10.01	1.07	1.43	0.71	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.95	0.93	0.69	0.46	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.11	1.36	0.79	0.79	0.65	0.07	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	5.80	0.00	0.39	0.39	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	1.72	0.00	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.20	5.41	3.69	4.18	1.48	0.25	0.25
Urethra, donor2	10319-105A4	95.32	10.79	5.40	5.40	5.40	0.00	1.80
Urothelial Cells, donor1	11520-119H8	2.92	0.27	0.00	0.53	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	0.00	0.40	1.60	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.13	0.46	0.00	0.00	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	14.71	1.78	0.45	1.34	1.34	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	92.54	9.79	3.56	1.78	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	100.07	12.87	5.72	4.29	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	51.34	10.95	3.42	6.16	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	67.83	13.08	5.17	3.10	2.41	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	73.79	8.72	6.39	2.91	4.65	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	81.22	7.29	2.08	2.08	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	94.53	12.85	6.42	2.75	4.59	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	4.56	3.65	0.91	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	21.22	3.33	1.11	1.85	1.11	0.12	0.37
Wilms' tumor cell line:HFWT	10597-108E3	18.48	9.68	0.88	2.64	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.82	1.12	2.23	0.28	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	35.13	6.20	2.07	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.16	1.27	1.02	0.76	0.76	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.03	9.75	4.64	2.79	4.18	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.64	12.11	3.68	6.77	3.80	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	26.67	6.53	1.36	6.80	2.72	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	52.84	11.81	5.62	5.62	2.25	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.24	6.56	1.69	4.23	1.90	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.97	4.08	1.09	3.54	0.82	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.45	6.61	2.64	4.85	3.97	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	56.35	2.45	2.04	3.27	1.23	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.12	11.26	3.88	2.33	3.11	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	22.26	2.02	0.92	0.74	1.29	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	7.80	7.80	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	51.36	3.95	2.09	2.56	0.93	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	42.20	7.25	3.88	2.85	1.55	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	42.08	3.51	2.92	2.63	2.34	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	35.79	1.39	1.39	2.79	1.86	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	15.22	5.76	1.65	2.06	0.41	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.59	2.15	0.31	0.92	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.56	3.84	1.28	2.13	3.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	21.23	2.73	1.52	1.52	1.21	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.79	4.81	2.41	2.65	1.44	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.27	2.00	0.00	1.78	1.56	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	32.69	6.34	2.00	2.67	2.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	53.89	18.58	11.15	13.01	9.29	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.37	6.78	1.51	5.65	2.26	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.87	6.98	4.36	2.18	1.74	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	67.48	11.25	0.00	11.25	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	23.79	3.30	1.41	1.41	1.88	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	26.06	3.26	2.17	1.55	0.78	0.00	0.00
adipose, donor1	10184-103D4	124.32	5.86	5.86	0.59	3.52	4.69	1.76
adipose, donor2	10185-103D5	28.79	4.87	2.43	1.22	1.22	1.62	0.41
adipose, donor3	10186-103D6	33.49	2.72	1.36	1.36	2.45	0.82	0.54
adipose, donor4	10187-103D7	44.20	1.73	2.60	0.87	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.56	3.16	1.42	0.95	2.68	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	3.64	3.64	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	50.29	4.14	3.34	2.67	1.33	0.40	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.94	6.07	4.64	3.93	1.43	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	30.14	4.17	2.55	4.87	1.62	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	26.03	3.04	2.03	2.03	1.35	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	34.17	5.01	2.36	2.65	2.36	0.00	0.00
amygdala - adult, donor10196	10167-103B5	54.55	9.49	3.56	1.19	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	66.51	8.11	5.27	2.23	1.82	1.01	0.81
amygdala, newborn, donor10223	10360-105E9	19.69	8.07	4.52	6.46	0.65	0.65	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	48.89	2.55	3.95	0.89	2.04	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.52	13.68	2.87	8.38	1.54	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.84	13.03	7.01	4.01	3.67	1.67	0.67
aorta, adult, pool1	10052-101G7	38.44	5.88	4.31	1.57	2.35	0.20	0.00
appendix, adult	10189-103D9	109.84	13.97	5.05	5.82	6.99	0.39	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.42	1.72	0.69	1.03	3.10	0.69	0.00
artery, adult	10190-103E1	40.76	9.51	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	36.94	2.46	2.75	1.59	1.45	0.29	0.43
b cell line:RPMI1788	10427-106D4	48.03	5.35	2.97	3.27	2.23	0.89	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.99	2.22	0.55	0.55	0.83	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.75	3.47	1.69	2.38	0.99	0.10	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	3.18	0.50	3.35	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	4.47	0.56	0.00	2.24	0.00	0.56
bladder, adult, pool1	10011-101C2	27.27	4.45	3.48	1.74	0.87	0.33	0.11
blood, adult, pool1	10053-101G8	22.15	8.86	4.43	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	4.28	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	38.47	4.72	2.02	1.35	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	31.78	2.05	1.03	1.03	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	23.61	2.90	1.34	0.78	0.89	0.78	0.00
brain, fetal, pool1	10085-102B4	37.40	2.67	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.52	5.62	2.97	3.63	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	55.17	5.12	2.50	5.24	2.50	0.25	0.12
breast, adult, donor1	10080-102A8	22.10	3.16	0.63	2.53	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.20	2.03	0.38	0.25	0.25	0.00	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.39	0.93	0.93	0.31	1.24	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	25.09	3.91	0.92	1.84	1.15	0.23	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.96	1.45	0.48	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	30.09	3.29	2.82	0.47	0.47	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	14.00	1.31	0.77	0.55	0.88	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	28.52	6.65	5.39	1.27	1.27	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	41.79	8.78	4.53	3.46	4.79	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	49.51	10.36	1.15	1.15	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.02	8.53	7.36	2.51	2.18	1.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	18.34	6.11	3.06	0.76	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	26.37	9.52	4.39	4.39	2.56	0.37	1.10
cerebellum - adult, donor10196	10173-103C2	75.75	20.39	8.74	0.00	20.39	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	144.12	16.01	13.88	5.55	5.55	3.42	0.21
cerebellum, adult, pool1	10083-102B2	41.74	10.00	5.17	2.76	3.79	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	113.75	65.59	44.01	15.78	15.78	0.00	0.00
cerebral meninges, adult	10188-103D8	19.92	5.04	0.50	1.01	0.50	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	21.93	8.04	6.58	1.46	4.39	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.11	3.74	1.29	1.58	0.58	0.14	0.14
cervical cancer cell line:ME-180	10553-107I4	16.24	1.16	1.33	0.99	0.66	0.33	0.17
cervix, adult, pool1	10013-101C4	49.77	7.56	4.20	1.78	1.68	0.00	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.22	2.37	1.81	1.39	1.11	0.00	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	1.31	5.23	1.31	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.99	2.24	2.11	0.87	2.86	0.50	0.12
choriocarcinoma cell line:SCH	10785-110H2	13.31	3.33	1.36	1.23	0.37	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	16.60	2.13	0.24	1.42	2.13	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	21.94	2.85	0.85	2.56	1.71	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	14.91	2.49	1.59	1.79	1.19	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	31.87	3.30	1.10	2.75	1.65	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	14.14	12.12	1.01	2.02	5.05	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.74	5.38	2.69	3.07	1.54	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.20	3.38	1.48	0.42	0.63	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	20.80	3.60	1.28	1.54	1.03	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	24.19	2.66	1.21	1.21	1.94	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	25.65	2.44	1.63	1.43	2.24	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	26.50	4.12	1.77	1.77	3.24	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	68.02	4.43	3.39	2.35	3.13	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.71	1.60	1.60	0.46	1.14	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.50	1.91	1.39	0.17	0.69	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	20.50	2.56	2.01	1.46	3.11	0.92	0.73
colon carcinoma cell line:COLO-320	10420-106C6	47.89	2.28	3.04	0.00	4.56	0.38	0.00
colon, adult, donor1	10082-102B1	48.79	2.38	0.00	1.19	0.00	3.57	0.00
colon, adult, pool1	10014-101C5	50.06	4.23	2.00	2.23	1.65	0.35	0.00
colon, fetal, donor1	10070-101I7	46.97	3.71	1.24	2.47	3.71	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	229.18	50.42	32.08	13.75	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	36.12	6.80	2.55	3.40	2.12	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.22	5.89	1.66	4.83	0.45	0.15	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	27.64	4.79	1.13	3.10	0.99	0.28	0.28
corpus callosum, adult, pool1	10042-101F6	70.32	6.41	5.20	1.99	2.54	0.66	0.33
cruciate ligament, donor2	10295-104G7	75.37	11.35	7.29	5.67	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	40.13	9.63	2.41	4.82	0.80	0.00	0.00
diencephalon, adult	10193-103E4	20.16	2.88	2.64	0.48	1.68	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.95	3.67	1.38	1.38	2.53	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.34	1.03	1.03	1.28	0.77	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.83	3.13	1.20	3.85	0.96	0.24	0.96
ductus deferens, adult	10196-103E7	71.76	7.48	2.49	2.49	3.99	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	64.81	17.28	4.32	2.88	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	83.86	13.98	5.89	1.47	1.47	0.00	0.74
dura mater, adult, donor1	10041-101F5	38.16	8.67	4.54	1.49	1.24	0.17	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.99	1.78	1.55	0.89	1.33	0.00	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.77	3.30	1.72	2.44	1.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	20.96	7.40	1.85	2.47	3.08	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.82	3.03	0.61	0.61	1.21	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.39	5.25	1.85	2.47	1.23	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	42.03	6.57	1.31	3.94	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	27.49	7.37	3.35	1.68	2.01	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.46	1.99	2.36	0.36	1.81	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	8.84	3.54	1.13	2.73	1.77	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	16.56	1.67	1.45	0.56	1.22	0.00	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.12	2.42	1.87	1.21	1.65	0.33	0.88
epididymis, adult	10197-103E8	61.75	6.70	4.19	1.47	3.35	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	37.79	4.26	1.60	1.60	1.95	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	3.93	0.79	0.79	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.75	4.06	2.62	2.23	0.92	0.66	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	19.68	2.56	1.57	1.18	1.57	0.49	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	23.97	2.35	2.13	2.02	1.46	0.00	0.45
esophagus, adult, pool1	10015-101C6	23.47	2.55	1.70	1.49	1.49	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	36.32	7.76	4.13	4.01	2.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	62.78	16.90	2.41	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	10.52	4.21	6.31	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	55.06	20.84	4.46	7.44	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	38.98	11.46	8.03	6.88	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	13.12	2.91	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	23.64	3.56	3.31	2.03	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	19.11	3.08	0.51	1.15	0.77	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.78	3.80	2.85	1.19	2.85	0.00	0.47
frontal lobe, adult, pool1	10040-101F4	60.33	7.79	4.97	2.53	2.72	0.19	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.33	4.80	3.90	1.50	2.40	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.56	1.10	0.91	0.55	0.64	0.00	0.09
gall bladder, adult	10198-103E9	55.77	5.55	3.14	2.66	3.14	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	70.86	17.72	6.98	4.83	2.15	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	58.64	16.06	5.23	4.11	4.86	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	5.07	2.11	1.69	1.27	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	42.36	3.09	1.93	0.77	1.74	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	46.24	4.59	2.46	3.61	1.97	0.16	0.66
gastric cancer cell line:GSS	10560-108A2	11.90	5.49	6.41	0.00	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.64	4.34	2.97	2.28	1.37	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	7.57	6.43	1.38	3.79	0.80	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	36.25	4.20	2.94	3.08	2.80	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.43	1.00	1.25	1.25	1.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.34	2.11	1.58	2.53	0.95	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.25	4.07	2.11	2.39	1.54	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	16.22	1.55	0.55	0.66	1.55	0.00	0.33
glioma cell line:GI-1	10413-106B8	19.62	4.39	1.46	1.76	0.59	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	39.36	12.39	5.10	2.19	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	100.57	10.50	10.74	4.88	5.61	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	53.40	16.43	4.11	5.48	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	19.72	6.93	3.20	6.93	3.73	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	166.41	44.05	12.24	26.92	17.13	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	2.56	1.92	2.88	1.60	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.09	3.21	1.84	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	23.32	1.37	1.83	0.91	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	23.83	1.29	1.29	0.64	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	2.87	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	20.58	2.06	1.37	0.69	0.69	0.69	1.37
hIPS, biol_rep3	14382-156B8	28.69	2.21	2.21	0.00	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	40.23	5.46	0.29	2.01	1.15	0.29	0.29
heart - mitral valve, adult	10205-103F7	78.03	9.87	4.78	4.78	3.29	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	75.04	7.06	3.66	2.88	3.40	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	113.24	24.98	8.33	9.99	7.49	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	17.75	2.04	1.43	0.20	1.02	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	23.42	2.13	1.70	1.28	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	13.34	2.07	1.15	0.23	0.92	0.23	0.00
heart, fetal, pool1	10046-101G1	62.63	6.26	3.39	1.03	2.57	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.04	2.47	0.62	1.54	0.93	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	44.00	10.70	2.38	3.57	2.38	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.50	3.20	3.09	2.54	2.32	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.52	3.64	3.52	3.03	2.43	0.24	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	35.87	4.14	4.24	2.83	2.22	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	19.69	2.67	0.89	0.89	1.22	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.20	3.12	1.61	2.01	0.90	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	44.48	7.57	1.89	0.95	3.79	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	78.99	9.39	7.14	4.29	2.45	1.02	0.20
hippocampus, adult, donor10258	10374-105G5	29.38	4.98	0.50	0.00	2.99	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	15.86	9.87	4.58	3.17	2.47	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	70.80	7.32	1.22	6.71	4.27	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	33.38	3.14	2.16	2.16	1.77	0.20	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	38.85	3.81	2.54	1.02	3.05	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	46.24	1.69	0.56	0.56	1.69	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.60	2.84	0.77	0.26	1.03	1.55	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.55	1.14	0.76	0.76	1.90	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	47.88	5.26	1.17	1.17	1.75	0.29	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	45.24	2.80	2.15	1.29	1.29	1.08	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	2.50	1.67	2.09	2.09	0.42	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	29.84	4.74	2.60	1.42	2.13	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.25	3.38	1.77	0.64	0.96	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	27.61	6.73	1.35	0.67	2.02	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.04	3.29	2.19	2.03	1.41	0.31	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	34.88	2.46	1.97	1.97	2.46	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	39.27	7.85	0.00	0.87	1.75	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.63	1.91	2.48	1.15	0.76	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.12	1.74	0.44	0.00	0.87	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	48.98	3.50	4.00	0.00	3.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	39.56	3.39	2.26	0.75	1.51	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	40.02	4.09	1.82	0.91	1.82	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	45.73	4.07	2.51	1.25	3.13	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	20.90	2.94	2.29	1.14	1.47	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.97	3.19	1.16	0.87	0.58	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.02	2.39	0.90	1.20	1.79	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.42	2.96	1.66	1.66	2.03	0.18	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	28.81	3.14	1.71	0.57	2.28	0.29	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	49.00	1.63	2.45	1.63	2.86	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	56.33	0.70	1.06	0.00	2.46	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	37.38	1.27	1.27	0.32	2.22	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	38.43	3.03	1.82	0.61	2.42	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.23	2.07	2.59	1.03	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.21	5.98	1.33	1.33	0.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.27	3.59	2.05	1.03	1.54	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.56	2.56	1.28	0.51	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.99	3.79	0.76	3.03	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.82	3.02	1.68	0.00	2.35	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	32.12	2.42	0.72	0.48	1.69	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	38.33	1.78	3.12	2.67	3.12	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.61	3.41	3.90	0.98	2.44	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	40.65	3.06	0.61	0.31	2.44	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	260.26	3.25	9.76	9.76	16.27	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	58.91	2.32	0.33	1.65	2.65	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.24	5.47	2.19	2.19	1.64	0.00	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.91	3.62	1.09	1.45	1.09	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.06	5.69	1.78	1.42	1.78	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	23.87	5.97	1.19	1.19	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	35.35	2.98	1.49	1.63	2.84	0.41	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.25	2.42	0.81	0.54	1.62	0.54	0.81
immature langerhans cells, donor1	11904-125F5	12.59	9.93	1.45	2.91	1.45	0.24	0.48
immature langerhans cells, donor2	11905-125F6	38.81	4.75	4.75	3.96	2.38	0.00	1.58
insula, adult, pool1	10039-101F3	54.41	6.06	3.22	1.89	2.56	0.76	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	7.48	0.33	0.65	0.00	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	30.34	3.90	1.60	3.30	1.40	0.00	0.20
kidney, fetal, pool1	10045-101F9	49.09	5.38	3.75	3.32	2.76	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	39.77	4.69	2.41	1.42	4.69	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.17	1.80	0.83	0.55	1.11	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.88	4.22	1.47	1.83	1.10	0.18	0.92
left atrium, adult, donor1	10079-102A7	11.44	0.54	0.54	0.00	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	6.07	1.01	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.62	4.10	1.92	1.92	2.19	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	4.67	0.00	0.72	1.44	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	5.98	1.63	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.34	2.43	0.49	0.97	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	23.00	10.46	0.00	3.14	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	39.31	4.49	2.83	2.13	1.65	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	26.71	5.94	2.97	2.66	1.56	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	18.64	1.22	1.95	0.49	1.71	0.12	0.00
liver, adult, pool1	10018-101C9	16.37	1.13	0.16	0.97	0.49	0.00	0.16
liver, fetal, pool1	10086-102B5	12.23	1.88	0.00	0.94	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	42.29	7.15	3.35	2.19	2.04	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	55.73	6.09	6.09	2.21	2.03	0.92	0.18
locus coeruleus, adult, donor10258	10375-105G6	20.03	2.82	0.85	1.41	0.85	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	45.43	8.41	4.63	5.47	3.36	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	7.61	1.11	0.55	0.97	0.42	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	24.13	2.76	1.38	2.07	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.13	1.45	0.79	0.40	0.79	0.13	0.26
lung, adult, pool1	10019-101D1	27.29	2.48	1.65	1.42	1.06	0.12	0.00
lung, fetal, donor1	10068-101I5	213.20	22.83	5.42	6.56	9.70	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	38.03	8.25	2.75	0.92	3.21	0.00	0.00
lymph node, adult, donor1	10077-102A5	20.83	2.84	0.95	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.92	1.32	0.66	0.66	1.32	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.26	1.96	1.06	0.45	1.21	0.30	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	40.78	4.25	5.10	2.55	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	41.74	8.44	1.78	6.22	4.88	0.00	0.44
mature adipocyte, donor2	12232-129F9	35.07	5.81	2.08	4.36	2.08	0.00	0.21
mature adipocyte, donor3	12233-129G1	25.60	3.32	2.61	4.03	0.71	0.24	0.24
mature adipocyte, donor4	12234-129G2	24.22	4.74	0.79	3.69	2.11	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	41.46	2.86	2.38	1.43	1.67	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	33.84	5.64	3.38	3.38	2.26	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	55.36	7.72	7.17	2.39	3.86	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	24.78	4.45	2.22	0.95	2.54	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	58.86	12.79	4.69	12.79	4.26	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	49.11	6.75	2.19	3.21	1.35	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	70.25	8.28	5.31	2.97	3.61	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	5.78	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	33.02	5.38	6.46	6.10	3.59	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	36.99	10.38	1.95	1.95	1.95	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	73.69	10.06	6.35	3.87	3.41	0.62	0.31
medulla oblongata, adult, pool1	10038-101F2	44.65	6.29	3.75	2.61	2.12	0.65	0.33
medulla oblongata, newborn, donor10223	10361-105F1	35.41	7.29	5.90	5.55	2.78	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	61.55	8.86	5.31	3.32	5.31	0.22	0.44
medulloblastoma cell line:ONS-76	10759-110E3	15.90	2.93	0.98	0.73	1.71	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	13.80	2.44	1.44	1.01	1.29	0.72	0.43
melanoma cell line:G-361	10465-106H6	26.06	3.26	3.53	0.54	0.54	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	23.70	1.99	2.35	0.36	0.72	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	63.44	7.05	6.17	0.88	3.52	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	75.43	9.33	7.52	3.37	7.52	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.74	3.07	0.15	1.53	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.54	2.18	0.18	0.73	0.55	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.28	1.24	0.41	2.48	1.24	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.03	2.53	0.42	1.40	1.12	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.25	3.47	0.58	0.58	0.77	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	17.35	4.16	2.78	2.78	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	2.57	0.69	1.37	0.51	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.96	2.19	0.35	1.96	0.58	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.13	2.52	0.13	1.99	1.19	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	14.45	3.51	1.08	0.95	0.81	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.65	2.56	0.28	2.70	1.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.75	3.29	0.33	2.96	1.32	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.40	4.01	0.83	2.77	0.55	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.36	1.75	0.00	1.75	1.05	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.64	2.04	0.61	1.84	1.02	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.30	1.08	0.72	1.80	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.21	3.72	0.52	1.03	0.83	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.30	2.74	0.91	2.74	0.91	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	2.10	1.68	3.78	2.52	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.44	3.74	0.60	1.79	1.20	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.33	2.80	1.05	2.63	1.31	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	3.68	2.95	1.84	2.58	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.02	4.29	1.72	2.29	0.57	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.47	3.79	1.68	1.68	2.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.87	0.91	1.37	0.00	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.49	3.84	0.77	1.02	1.02	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.73	3.66	0.79	0.26	1.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.93	2.77	1.54	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.30	1.65	0.47	0.71	0.94	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.12	1.35	1.02	1.02	2.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	1.57	0.79	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	1.39	0.93	0.00	1.39	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	3.17	0.87	0.58	1.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.70	2.23	0.89	0.67	0.45	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.09	1.68	0.48	0.96	0.96	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	2.20	0.73	0.73	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.71	1.01	0.67	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.05	1.64	1.23	1.64	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	2.58	1.29	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.02	1.95	0.32	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	0.00	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.53	3.20	1.07	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.91	0.82	0.82	0.00	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.61	2.72	0.39	1.17	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00	2.10	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	2.98	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	2.37	1.19	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	0.00	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	1.90	2.53	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.59	1.38	0.69	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	0.81	0.41	1.63	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	0.00	0.00	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	9.43	1.77	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.73	1.87	0.62	0.31	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	1.34	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	1.18	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	0.00	0.69	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	1.98	1.98	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	1.12	1.12	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	0.64	2.54	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	3.22	1.21	0.81	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	4.36	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	0.00	0.00	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.06	5.46	4.25	1.82	1.82	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	4.12	0.82	0.82	4.12	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.13	2.78	0.20	2.58	0.79	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.52	1.95	1.95	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	3.06	5.09	0.00	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	9.28	0.77	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	23.62	10.63	3.31	7.32	1.65	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.35	4.17	1.62	4.87	1.62	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	9.35	2.47	1.34	2.47	1.03	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	7.72	1.13	0.68	1.36	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	8.56	2.93	0.24	1.22	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	9.96	1.33	1.55	0.66	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	18.40	2.63	1.31	1.58	0.26	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	14.13	3.74	1.53	2.04	1.36	0.34	0.85
mesothelioma cell line:Mero-84	10855-111F9	3.79	1.52	0.51	0.51	0.76	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	12.42	1.86	1.86	1.45	0.41	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	13.42	2.82	1.49	1.33	1.16	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	6.88	4.52	0.36	3.08	0.54	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	9.22	1.37	0.17	0.51	0.68	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	21.12	2.54	2.04	2.54	0.76	0.00	0.00
mesothelioma cell line:No36	10857-111G2	12.07	1.96	2.28	1.30	1.63	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	10.30	2.98	0.81	1.90	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	22.84	3.84	1.54	2.88	0.19	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	26.99	5.86	1.59	3.30	1.47	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	58.69	4.85	1.26	2.87	0.72	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	24.49	2.94	1.31	0.33	3.26	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.50	2.76	0.21	0.42	1.70	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	17.05	2.99	0.23	1.38	1.38	0.00	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.89	3.04	1.14	1.52	1.14	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.61	3.33	3.14	2.22	2.40	0.74	0.00
myeloma cell line:PCM6	10474-106I6	11.27	2.57	0.79	1.58	0.59	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	0.51	1.52	0.51	1.52	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.79	1.57	0.78	0.39	0.59	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.60	1.00	0.67	0.67	0.89	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.65	1.18	0.96	0.96	0.59	0.00	0.37
nasal epithelial cells, donor2	12227-129F4	14.35	3.31	0.00	1.10	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	86.96	12.42	5.06	1.38	5.06	1.15	0.00
neuroblastoma cell line:NB-1	10539-107G8	62.30	8.04	3.74	2.81	4.30	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	18.77	3.37	2.32	1.48	2.95	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	78.27	8.94	5.40	1.49	4.47	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	56.93	10.20	3.32	1.19	3.08	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	32.47	5.86	5.38	2.69	1.74	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	13.28	4.43	1.01	2.42	0.81	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	11.44	8.90	1.27	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.11	2.93	1.33	0.80	0.80	0.00	0.27
neutrophil PMN, donor1	12133-128D9	59.50	74.37	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	77.29	4.06	1.18	0.68	0.51	0.85	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.01	1.60	1.60	1.60	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.99	2.56	0.96	0.96	1.28	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	10.77	1.84	1.58	2.10	0.53	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	49.12	7.59	3.94	2.25	1.97	0.56	0.09
occipital cortex - adult, donor10196	10172-103C1	57.69	8.24	2.06	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	101.44	16.10	7.78	4.83	5.10	2.42	0.00
occipital cortex, newborn, donor10223	10355-105E4	26.57	8.73	4.00	9.10	1.46	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	23.35	2.62	2.10	1.31	1.57	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	78.53	17.16	8.15	2.15	9.44	0.43	0.00
occipital pole, adult, pool1	10036-101E9	31.38	4.18	1.73	0.95	1.34	0.47	0.00
olfactory region, adult	10195-103E6	44.52	6.30	3.06	1.91	1.15	0.76	0.19
optic nerve, donor1	10277-104E7	42.02	14.01	12.01	12.01	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	15.49	3.65	1.71	1.48	1.03	0.00	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.24	3.30	2.20	2.06	3.30	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.41	3.89	1.52	1.69	2.03	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.90	1.96	0.35	0.69	1.62	0.00	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	18.23	2.06	0.29	1.18	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	29.90	4.67	3.74	3.74	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	22.48	4.67	3.18	4.45	2.76	0.21	0.00
ovary, adult, pool1	10020-101D2	27.43	4.37	2.97	1.40	2.10	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.52	4.95	2.20	2.38	1.65	0.18	0.18
pancreas, adult, donor1	10049-101G4	23.52	5.64	0.94	1.88	2.82	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.73	3.07	1.12	0.28	1.68	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	17.21	2.73	2.21	1.19	1.36	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.63	2.32	1.49	0.99	1.16	0.00	0.66
paracentral gyrus, adult, pool1	10035-101E8	49.33	4.76	2.56	1.65	2.29	0.55	0.64
parietal cortex, adult, donor10258	10373-105G4	37.43	2.94	2.94	0.73	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	53.61	5.64	5.64	3.76	6.58	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	76.10	8.27	5.42	1.71	4.28	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	51.29	5.55	4.85	2.56	3.44	0.53	0.09
parietal lobe, fetal, donor1	10072-101I9	104.74	28.13	6.79	5.82	16.49	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	31.40	14.21	2.24	7.85	3.36	1.87	1.50
parotid gland, adult	10199-103F1	32.68	3.70	1.23	1.23	0.62	0.00	0.00
penis, adult	10200-103F2	63.38	4.83	4.30	0.54	0.00	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.90	7.07	3.53	3.35	2.60	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.87	1.75	1.75	1.02	1.31	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	66.44	5.16	3.23	0.65	2.58	0.00	2.58
pineal gland, adult, donor10252	10160-103A7	128.51	7.11	7.70	4.74	5.92	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	31.98	5.02	7.52	0.63	2.51	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	94.10	10.12	8.09	1.01	8.09	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	125.60	13.55	8.86	3.65	5.73	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	40.01	10.21	5.11	0.00	3.40	0.85	0.00
placenta, adult, pool1	10021-101D3	22.25	6.67	4.41	5.38	2.26	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	18.41	1.46	0.66	0.40	0.79	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.10	4.36	4.36	2.18	1.09	0.16	0.16
pons, adult, pool1	10033-101E6	43.72	6.28	3.44	2.32	1.46	0.43	0.17
postcentral gyrus, adult, pool1	10032-101E5	37.75	4.53	4.01	1.31	1.92	0.26	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	81.56	27.19	10.46	10.46	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.96	1.46	0.44	1.46	0.00	0.15	0.58
prostate cancer cell line:PC-3	10439-106E7	33.40	8.89	4.72	11.25	2.54	0.18	0.54
prostate, adult, pool1	10022-101D4	42.26	5.71	4.63	1.90	1.81	0.36	0.00
putamen, adult, donor10196	10176-103C5	54.77	8.03	6.61	3.78	1.89	0.94	0.24
putamen, adult, donor10252	10152-102I8	41.18	13.73	15.69	5.88	3.92	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	8.74	0.00	1.09	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.33	6.52	2.90	1.45	0.72	0.72	0.00
putamen, newborn, donor10223	10365-105F5	29.99	5.25	3.75	3.75	3.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	20.07	2.33	1.75	2.04	1.16	0.00	0.29
rectum, fetal, donor1	10067-101I4	63.99	22.26	4.17	4.17	9.74	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	7.84	1.06	0.85	1.06	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.47	0.00	0.83	0.41	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	53.08	7.26	4.37	1.69	3.48	0.30	0.50
retinoblastoma cell line:Y79	10475-106I7	48.32	6.50	4.16	0.78	5.72	1.56	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.48	5.04	2.21	1.84	1.48	0.37	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	55.12	13.50	7.87	5.62	6.47	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.10	9.85	1.52	3.03	2.27	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.99	1.29	0.32	0.81	1.13	0.00	0.00
salivary acinar cells, donor2	11772-123I8	20.79	2.34	1.24	0.41	1.24	0.00	0.00
salivary acinar cells, donor3	11773-123I9	35.75	4.63	1.32	0.66	3.97	0.00	0.00
salivary gland, adult, pool1	10093-102C3	57.77	9.72	1.72	0.57	5.15	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.08	3.54	1.69	0.84	0.67	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	20.69	2.94	1.76	1.06	2.00	0.12	0.00
seminal vesicle, adult	10201-103F3	64.55	11.11	3.70	2.12	6.35	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.65	2.92	0.97	1.21	1.21	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	9.31	1.26	0.25	0.25	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	1.00	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	21.36	2.01	1.61	4.03	3.22	0.27	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	27.96	1.88	0.99	1.99	1.22	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.48	0.77	0.77	0.52	0.65	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	26.25	7.09	5.67	2.84	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	20.87	1.56	2.76	0.84	0.84	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	9.05	2.01	0.00	3.02	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.71	11.36	5.68	1.26	3.79	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.69	8.34	3.00	2.00	1.67	0.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	120.41	17.65	10.40	5.99	8.51	0.32	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	30.07	4.43	1.93	3.47	2.89	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	32.14	1.65	0.82	0.99	0.82	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.89	4.83	4.99	1.29	2.25	0.97	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.37	5.45	3.70	2.83	4.36	0.65	0.87
small intestine, adult, pool1	10024-101D6	60.68	5.37	2.39	5.61	2.51	0.60	0.24
small intestine, fetal, donor1	10064-101I1	32.92	3.69	0.98	1.72	1.47	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.24	3.08	0.51	2.56	1.03	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	55.31	6.20	4.65	1.03	0.52	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	13.40	1.61	1.07	0.80	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	44.28	7.57	4.36	2.98	1.61	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	96.20	11.83	5.52	5.13	2.76	1.97	1.18
spinal cord, adult, donor10258	10369-105F9	42.20	8.30	5.53	0.69	0.00	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	56.10	8.54	1.22	1.83	3.66	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	55.56	10.56	8.73	7.81	4.59	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.52	4.03	1.49	3.14	1.34	0.00	0.30
spleen, adult, pool1	10025-101D7	38.77	4.52	1.76	0.99	1.21	0.00	0.11
spleen, fetal, pool1	10044-101F8	64.36	7.23	3.97	2.54	2.15	0.79	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	28.78	3.42	1.97	1.55	1.55	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.48	0.76	0.57	0.19	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	22.02	2.10	1.05	1.05	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	15.25	4.69	1.95	1.56	1.95	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.39	3.60	2.81	1.58	2.14	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	7.62	1.69	0.00	0.85	1.27	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	1.27	0.00	0.85	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	56.60	10.68	2.14	2.14	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	54.12	8.55	3.42	2.85	1.71	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	81.84	7.89	4.78	3.74	3.12	1.04	0.42
substantia nigra, adult, donor10258	10371-105G2	26.38	9.31	2.59	2.07	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.02	7.77	2.83	2.12	2.83	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	31.41	4.59	0.92	1.38	1.15	0.69	0.00
temporal lobe, adult, pool1	10031-101E4	30.01	4.58	2.63	1.44	1.86	0.42	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	92.59	21.37	12.11	9.26	9.97	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	80.88	15.38	7.03	2.64	7.03	0.44	0.44
tenocyte, donor1	11763-123H8	18.50	3.84	1.05	1.05	1.05	0.35	0.00
tenocyte, donor2	11765-123I1	20.22	2.29	0.76	1.91	1.91	0.00	0.00
tenocyte, donor3	11768-123I4	13.71	2.22	0.74	1.11	0.74	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	42.83	3.74	1.70	1.02	2.04	0.34	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	32.83	3.85	3.55	1.70	3.24	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	26.81	3.56	1.39	0.62	0.93	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.44	3.43	2.79	2.03	1.40	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.52	6.43	6.05	3.03	4.16	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	33.92	2.84	1.09	1.20	2.07	0.33	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	49.51	10.10	8.79	1.95	3.91	0.00	0.00
testis, adult, pool1	10026-101D8	28.67	5.69	2.04	5.37	2.15	0.11	0.64
testis, adult, pool2	10096-102C6	64.51	22.10	5.41	4.96	5.41	0.45	2.26
thalamus - adult, donor10196	10168-103B6	73.97	8.83	4.42	1.10	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	78.61	12.66	9.53	4.06	2.81	0.63	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	6.16	0.00	0.00	9.24	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.63	1.48	0.99	0.99	0.99	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	14.38	6.33	5.75	1.73	2.30	1.73	0.58
throat, adult	10209-103G2	50.68	6.49	3.75	2.00	3.50	0.25	0.00
throat, fetal, donor1	10061-101H7	53.93	17.67	6.40	1.83	2.44	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	38.95	6.76	3.78	3.97	4.37	0.00	1.99
thymus, adult, pool1	10027-101D9	38.57	10.34	4.37	2.29	1.99	0.20	0.00
thymus, fetal, pool1	10043-101F7	118.66	20.26	8.52	7.48	5.92	1.56	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.09	2.13	0.80	1.06	0.53	0.00	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	21.65	2.79	2.37	1.12	1.54	0.56	0.28
thyroid, adult, pool1	10028-101E1	29.11	7.19	2.89	3.36	2.05	0.28	0.09
thyroid, fetal, donor1	10060-101H6	64.86	15.82	10.02	5.54	5.01	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	86.23	18.48	21.56	3.08	12.32	0.00	0.00
tongue, adult	10203-103F5	33.03	3.72	2.09	1.16	1.40	0.23	0.00
tongue, fetal, donor1	10059-101H5	31.13	2.36	2.36	1.97	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	71.63	8.11	5.61	3.41	2.80	1.00	1.80
trachea, adult, pool1	10029-101E2	26.01	4.09	2.04	2.29	1.31	0.08	0.41
trachea, fetal, donor1	10058-101H4	35.01	9.62	3.85	3.46	2.31	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.73	2.83	0.71	0.35	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	25.53	3.24	1.72	2.13	1.11	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	26.64	4.86	1.88	2.51	2.19	0.78	0.16
tridermal teratoma cell line:HGRT	10694-109G1	26.64	5.71	3.81	3.81	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.38	1.44	0.93	0.51	1.02	0.08	0.34
umbilical cord, fetal, donor1	10057-101H3	16.69	10.43	2.09	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	112.61	14.84	3.41	3.24	6.83	0.68	0.00
uterus, fetal, donor1	10055-101H1	49.66	7.17	3.07	1.54	2.56	1.54	0.00
vagina, adult	10204-103F6	45.88	7.11	7.75	4.52	3.88	0.00	0.00
vein, adult	10191-103E2	48.66	6.58	3.07	0.88	1.97	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.44	4.27	1.87	1.07	0.80	1.07	0.27

Property "Nearest transcripts" (as page type) with input value "ENST00000434592.5:9 EF566883:9 EF566884:9 EF566885:9 BC046643:13 AF042857:14 ENST00000422955.5:-33 ENST00000493652.1:-38 AL832236:-39 AF069517:-40 ENST00000441115.5:-61 ENST00000419610.5:-72 AK298108:-72 AK291719:-91 ENST00000443081.5:-94 ENST00000442092.5:-128 LF378455:137 MA614032:137 ENST00000433811.1:284 ENST00000491874.5:362" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.